Binosto
- Product NDC
- 17139-400
- 11-digit product format
- 171390400
- Labeler code
- 17139
- Product ID
- 17139-400_ec1bfaa8-1f9f-bd6f-e053-2a95a90a9b3e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- alendronate sodium
- Dosage form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Labeler
- ASCEND Therapeutics U.S., LLC
- Application
- NDA202344
- Marketing category
- NDA
- Marketing start
- 2012-09-03
- Marketing end
- 0000-00-00
- Substance
- ALENDRONATE SODIUM
- Active strength
- 70 mg/1
- Pharmacologic classes
- Bisphosphonate [EPC], Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b55122e7-1795-3be6-8216-d42256d80e7d | Product name | 2 | 20250224 |
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| c3d77bcb-5cf1-4ea6-9307-38d8932a8b0a | Product name | 1 | 20240513 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
| c00e0569-fbc4-d31d-3ec8-d316fcedaffc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17139-400-01 | Binosto | 1 in 1 CARTON | TABLET, EFFERVESCENT | 1 | 23 | |
| 17139-400-04 | Binosto | 4 in 1 CARTON | TABLET, EFFERVESCENT | 4 | 23 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17139-400-00 | EA - Each | 17139-400 | 19e2b147-c475-4499-a468-28e1797caa22 | 1 | 2020-01-03 |
| 17139-400-04 | EA - Each | 17139-400 | 96205f5f-4277-4ba0-8202-1fc2a29c148f | 1 | 2020-01-03 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1248077 | alendronate sodium 70 MG Effervescent Oral Tablet | PSN | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248083 | Binosto 70 MG Effervescent Oral Tablet | PSN | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248083 | alendronic acid 70 MG Effervescent Oral Tablet [Binosto] | SBD | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248077 | alendronic acid 70 MG Effervescent Oral Tablet | SCD | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248077 | alendronic acid (as alendronate sodium) 70 MG Effervescent Oral Tablet | SY | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248083 | Binoso (alendronic acid 70 MG (as alendronate sodium)) Effervescent Oral Tablet | SY | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
| 1248083 | Binosto 70 MG Effervescent Oral Tablet | SY | b278a11a-b8d7-49f3-9b38-29b67c4c417e | 23 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 17139-400-01 | 17139040001 | 1 TABLET, EFFERVESCENT in 1 CARTON (17139-400-01) | 2019-11-27 | 0000-00-00 | No | No | Current |
| 17139-400-04 | 17139040004 | 4 TABLET, EFFERVESCENT in 1 CARTON (17139-400-04) | 2019-11-27 | 0000-00-00 | No | No | Current |